High-Flying Novo Nordisk Dips On Disappointing Data for Weight-Loss Pill
Novo Nordisk’s American depositary receipts tumbled almost 6% Friday after the drugmaker reported mixed results from a study of an experimental weight-loss pill. The pill, monlunabant, helped people ...
WSAY4m
Novo Nordisk shares drop nearly 5% on disappointing obesity pill data
By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -Novo Nordisk's shares fell nearly 5% on Friday after ...
Interaksyon on MSN40m
EU regulator backs use of Novo’s Wegovy for obesity-related heart condition
The European Medicines Agency backed the use of Novo Nordisk's NOVOb.CO popular drug Wegovy to help ease heart failure in ...
TAG24 NEWS on MSN3m
Obesity drug liraglutide helps children lose weight, study shows
Severe obesity is already a significant problem for many children, especially since obese children often become obese adults. Could the now popular weight-loss injection drugs be a solution for those ...
Rates to plunge to 2.75pc next year, says HSBC
The Bank of England could cut interest rates to 2.75pc next year, analysts have suggested, amid growing confidence that the ...